Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.

Huijbers MJ, Spinhoven P, Spijker J, Ruhé HG, van Schaik DJ, van Oppen P, Nolen WA, Ormel J, Kuyken W, van der Wilt GJ, Blom MB, Schene AH, Rogier A, Donders T, Speckens AE.

Br J Psychiatry. 2016 Apr;208(4):366-73. doi: 10.1192/bjp.bp.115.168971. Epub 2016 Feb 18.

2.

Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.

Huijbers MJ, Spinhoven P, Spijker J, Ruhé HG, van Schaik DJ, van Oppen P, Nolen WA, Ormel J, Kuyken W, van der Wilt GJ, Blom MB, Schene AH, Donders AR, Speckens AE.

J Affect Disord. 2015 Nov 15;187:54-61. doi: 10.1016/j.jad.2015.08.023. Epub 2015 Aug 18.

PMID:
26318271
3.

The effectiveness of the cognitive behavioral analysis system of psychotherapy for chronic depression: a randomized controlled trial.

Wiersma JE, Van Schaik DJ, Hoogendorn AW, Dekker JJ, Van HL, Schoevers RA, Blom MB, Maas K, Smit JH, McCullough JP Jr, Beekman AT, Van Oppen P.

Psychother Psychosom. 2014;83(5):263-9. doi: 10.1159/000360795. Epub 2014 Aug 6.

PMID:
25116461
4.

Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Mesa A, Somarelli JA, Wu W, Martinez L, Blom MB, Greidinger EL, Herrera RJ.

Lupus. 2013 Nov;22(13):1371-81. doi: 10.1177/0961203313508444.

5.

[Depressive disorders in ethnic minorities in the doctor's office].

Veling W, Blom MB, Hoek HW.

Ned Tijdschr Geneeskd. 2013;157(14):A5606. Review. Dutch.

PMID:
23548186
6.

Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.

Huijbers MJ, Spijker J, Donders AR, van Schaik DJ, van Oppen P, Ruhé HG, Blom MB, Nolen WA, Ormel J, van der Wilt GJ, Kuyken W, Spinhoven P, Speckens AE.

BMC Psychiatry. 2012 Aug 27;12:125. doi: 10.1186/1471-244X-12-125.

7.

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x.

PMID:
21320258
8.

Treatment of depression in patients from ethnic minority groups in the Netherlands.

Blom MB, Hoek HW, Spinhoven P, Hoencamp E, Judith Haffmans PM, van Dyck R.

Transcult Psychiatry. 2010 Jul;47(3):473-90. doi: 10.1177/1363461510374561.

PMID:
20688800
9.

Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Acta Psychiatr Scand. 2010 Sep;122(3):246-54. doi: 10.1111/j.1600-0447.2009.01537.x. Epub 2010 Feb 5.

PMID:
20136801
10.

[Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy (CBASP)].

Wiersma JE, van Schaik DJ, Blom MB, Bakker L, van Oppen P, Beekman AT.

Tijdschr Psychiatr. 2009;51(10):727-36. Review. Dutch.

11.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
12.

Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.

Wiersma JE, van Schaik DJ, van Oppen P, McCullough JP Jr, Schoevers RA, Dekker JJ, Blom MB, Maas K, Smit JH, Penninx BW, Beekman AT.

BMC Psychiatry. 2008 Mar 25;8:18. doi: 10.1186/1471-244X-8-18.

13.

Combination treatment for acute depression is superior only when psychotherapy is added to medication.

Blom MB, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, van Dyck R.

Psychother Psychosom. 2007;76(5):289-97.

PMID:
17700049
14.

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.

Blom MB, Spinhoven P, Hoffman T, Jonker K, Hoencamp E, Haffmans PM, van Dyck R.

J Affect Disord. 2007 Dec;104(1-3):119-26. Epub 2007 Apr 27.

PMID:
17467059
15.

Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.

Palmero EI, Ashton-Prolla P, da Rocha JC, Vargas FR, Kalakun L, Blom MB, Azevedo SJ, Caleffi M, Giugliani R, Schüler-Faccini L.

J Genet Couns. 2007 Jun;16(3):363-71. Epub 2007 Feb 23.

PMID:
17318454
16.

[The Multidisciplinary Guideline for Depression: a commentary].

Spijker J, Huyser J, Blom MB.

Tijdschr Psychiatr. 2006;48(12):921-5. Dutch.

17.

The influence of depressive state features on trait measurement.

Griens AM, Jonker K, Spinhoven P, Blom MB.

J Affect Disord. 2002 Jun;70(1):95-9.

PMID:
12113925
18.

[Pastoral work and crisis intervention].

Blom MB.

Tijdschr Ziekenverpl. 1974 Jun 4;27(23):518-23. Dutch. No abstract available.

PMID:
4495633

Supplemental Content

Loading ...
Support Center